Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Nasal Cavity Squamous Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01637194
What this trial is testing

Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer

Who this might be right for
Recurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the LipRecurrent Colon Cancer+46 more
Fox Chase Cancer Center 12
Testing effectiveness (Phase 2)WithdrawnNCT00095641
What this trial is testing

S0225 Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck Cancer

Who this might be right for
Recurrent Squamous Cell Carcinoma of the Lip and Oral CavityRecurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal CavityRecurrent Squamous Cell Carcinoma of the Hypopharynx+2 more
SWOG Cancer Research Network
Not applicableStudy completedNCT00809016
What this trial is testing

PET Scans in Patients With Head And Neck Cancer Who Are Undergoing 3-Dimensional Conformal Radiation Therapy And Intensity-Modulated Radiation Therapy

Who this might be right for
Head and Neck Cancer
Centre Oscar Lambret 40
Large-scale testing (Phase 3)Study completedNCT00002888
What this trial is testing

Combination Chemotherapy in Treating Patients With Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Eastern Cooperative Oncology Group
Early research (Phase 1)Study completedNCT00006036
What this trial is testing

Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Head and Neck CancerLung CancerOvarian Cancer+1 more
NCIC Clinical Trials Group 14
Testing effectiveness (Phase 2)Study completedNCT00096512
What this trial is testing

S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+34 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT00507767
What this trial is testing

Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+33 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT00002922
What this trial is testing

Paclitaxel in Treating Patients With Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Eastern Cooperative Oncology Group
Early research (Phase 1)WithdrawnNCT00006106
What this trial is testing

ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer

Who this might be right for
Lip and Oral Cavity CancerHead and Neck CancerOropharyngeal Cancer
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00062348
What this trial is testing

Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases

Who this might be right for
Colorectal CancerHead and Neck CancerMetastatic Cancer
European Organisation for Research and Treatment of Cancer - EORTC 27
Testing effectiveness (Phase 2)Study completedNCT00738868
What this trial is testing

Cetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery

Who this might be right for
Head and Neck Cancer
Centre Oscar Lambret 45
Testing effectiveness (Phase 2)Study completedNCT00509665
What this trial is testing

Gemcitabine and Doxorubicin in Treating Patients With Recurrent or Progressive Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Medical University of South Carolina 18
Testing effectiveness (Phase 2)Ended earlyNCT00062387
What this trial is testing

Perifosine in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
National Cancer Institute (NCI) 46
Testing effectiveness (Phase 2)Study completedNCT01816984
What this trial is testing

PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+33 more
University of Chicago 12
Testing effectiveness (Phase 2)Study completedNCT00021333
What this trial is testing

Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer

Who this might be right for
Head and Neck CancerLung Cancer
Fox Chase Cancer Center 29
Testing effectiveness (Phase 2)UnknownNCT00022217
What this trial is testing

Cisplatin-Epinephrine Injectable Gel Plus Paclitaxel and Carboplatin in Treating Patients With Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Matrix Pharmaceutical
Testing effectiveness (Phase 2)Study completedNCT00006248
What this trial is testing

S0007 - Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
SWOG Cancer Research Network 78
Early research (Phase 1)Study completedNCT00006981
What this trial is testing

Immunotoxin Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Cervical CancerFallopian Tube CancerHead and Neck Cancer+5 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT02035527
What this trial is testing

Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+34 more
Ohio State University Comprehensive Cancer Center 3
Early research (Phase 1)Ended earlyNCT01528137
What this trial is testing

Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+43 more
Stanford University 4
Next Page